Information was received from a healthcare professional (hcp) via a clinical study regarding a patient receiving hydromorphone, bupivacaine, and clonidine via an implantable pump.It was reported the patient's it rate was increased, on (b)(6) 2021, in effort to achieve improved lower back and lower extremity pain.The clinical diagnosis was worsening lower back and lower extremity pain.A catheter access port dye study was ordered.It was indicated the event was related to the device or therapy and possibly related to the hydromorphone, bupivacaine, and clonidine.The event was ongoing.Additional information was received from the healthcare provider via a clinical study indicated that the patient experienced intermittent worsening of numbness.The it rate was decreased and the entire catheter was explanted and replaced secondary to catheter fracture.
|